Technical Analysis for RX - BioSyent Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | -0.44% | |
| Crossed Above 50 DMA | Bullish | -0.44% | |
| 180 Bullish Setup | Bullish Swing Setup | -0.44% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | -0.44% | |
| Pocket Pivot | Bullish Swing Setup | -0.44% | |
| Volume Surge | Other | -0.44% | |
| Gapped Up | Strength | -0.44% | |
| 50 DMA Resistance | Bearish | 3.12% | |
| 20 DMA Resistance | Bearish | 2.93% | |
| Fell Below 50 DMA | Bearish | 2.93% |
| Alert | Time |
|---|---|
| 50 DMA Support | about 7 hours ago |
| 20 DMA Support | about 7 hours ago |
| 10 DMA Support | about 7 hours ago |
| Gapped Down (Full) | about 8 hours ago |
| Down 1 ATR | about 8 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 2024-11-14
BioSyent Inc. Description
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its subsidiary, BioSyent Pharma Inc., acquires or in-licenses and develops pharmaceutical products for sale in Canada and certain international markets. It has four business units: the Community and Women's Health Unit, which commercializes pharmaceutical products focused on improving family and women's health; the Hospital Business Unit, which sells pharmaceutical products to hospitals and hospital specialists; the International Pharmaceutical Unit, and the Legacy Business. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System and Cysview. FeraMAX 150 is an oral hematinic indicated for the prevention and treatment of iron deficiency anemia. Cathejell is indicated for surface anesthesia and lubrication for various procedures. RepaGyn helps relieve dryness and promotes healing of the vaginal mucosa. It also manufactures and markets Protect-It, a non-toxic product.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharma Pharmaceutical Pharmaceutical Products Anemia Cnx Nifty Iron Deficiency
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.49 |
| 52 Week Low | 8.06 |
| Average Volume | 4,443 |
| 200-Day Moving Average | 9.689 |
| 50-Day Moving Average | 10.983 |
| 20-Day Moving Average | 11.154 |
| 10-Day Moving Average | 11.077 |
| Average True Range | 0.242 |
| RSI (14) | 55.56 |
| ADX | 6.48 |
| +DI | 28.939 |
| -DI | 24.239 |
| Chandelier Exit (Long, 3 ATRs) | 10.763 |
| Chandelier Exit (Short, 3 ATRs) | 11.487 |
| Upper Bollinger Bands | 11.485 |
| Lower Bollinger Band | 10.822 |
| Percent B (%b) | 0.72 |
| BandWidth | 5.951 |
| MACD Line | 0.026 |
| MACD Signal Line | 0.044 |
| MACD Histogram | -0.0187 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.765 | ||||
| Resistance 3 (R3) | 11.713 | 11.507 | 11.688 | ||
| Resistance 2 (R2) | 11.507 | 11.388 | 11.533 | 11.662 | |
| Resistance 1 (R1) | 11.403 | 11.315 | 11.455 | 11.455 | 11.636 |
| Pivot Point | 11.197 | 11.197 | 11.223 | 11.223 | 11.197 |
| Support 1 (S1) | 11.093 | 11.078 | 11.145 | 11.145 | 10.964 |
| Support 2 (S2) | 10.887 | 11.005 | 10.913 | 10.938 | |
| Support 3 (S3) | 10.783 | 10.887 | 10.913 | ||
| Support 4 (S4) | 10.835 |
